In addition, CDKN2A expression levels were associated with the prognosis of patients with ACC, COAD, ESCA, HNSCC, KICH, KIRC, KIRP, LGG, LIHC, MESO, PRAD, UCEC in disease-specific survival, disease-free survival interval, and progression-free interval patients. The gene discussed is CDKN2A; the disease is adrenal cortex carcinoma.